Research programme: red blood cell growth factor - Interneuron

Drug Profile

Research programme: red blood cell growth factor - Interneuron

Alternative Names: Red blood cell growth factor research programme - Interneuron; Red blood cell growth factor research programme - ZymoGenetics; Research programme: red blood cell growth factor - ZymoGenetics

Latest Information Update: 13 Jul 1999

Price : $50

At a glance

  • Originator Indevus Pharmaceuticals
  • Developer Indevus Pharmaceuticals; ZymoGenetics
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anaemia

Most Recent Events

  • 13 Jul 1999 Discontinued-Preclinical for Anaemia in USA (Unknown route)
  • 13 Jul 1999 Research programme: red blood cell growth factor - Progenitor is now called Research programme: red blood cell growth factor - Interneuron
  • 10 Feb 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top